Introduction
Beginning in December 2019, a serial pneumonia outbreak reported in
Wuhan City, Hubei Province, China. Further investigations revealed it
was a new type of coronavirus, which was termed COVID-19. Symptoms are
variable and nonspecific, include dry cough, fever, dyspnea, fatigue,
myalgia, and anosmia1. The real-time
reverse-transcription polymerase chain reaction (rRT-PCR) test is the
current diagnostic method for confirming infection, performed using
nasal or pharyngeal swab specimens.
CT thorax, as a routine imaging tool for pneumonia diagnosis, is of
great importance in the early detection
and treatment of patients affected by COVID-19. It may detect the early
parenchymal abnormalities in the
absence of positive rRT-PCR at initial presentation 2.
Numerous classical chest CT findings of this disease were described such
as bilateral multi-lobar ground-glass opacification (GGO) with a
prevalent peripheral or posterior distribution, mainly in the lower
lobes, and sometimes consolidative opacities superimposed on GGOs could
be found 3. Up to our knowledge, bronchiectasis is not
a classical finding in COVID-19 pneumonia with a paucity of reporting
its development and progression during the disease.